Company News

Amyris and Givaudan Close Deal

Long-term manufacturing agreement for Neossance Squalane, Neossance Hemisqualane and CleanScreen.

Author Image

By: Christine Esposito

Editor-in-Chief

Amyris, Inc. has completed the previously announced strategic transaction with Givaudan SA for the worldwide exclusive licensing of certain cosmetic ingredients, including Neossance Squalane, Neossance Hemisqualane and CleanScreen. “We are very pleased with the expansion of our long-term partnership with Givaudan,” said John Melo, president and CEO. “This transaction marks the continuation of the successful execution of our strategy to develop, scale and make the world'...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters